Gelaspan 4%

DRUG3 trials

Sponsors

Fakultni Nemocnice Brno, B. Braun Melsungen AG, B. Braun Medical LLC

Conditions

HypovolemiaTreatment of Hypovolemia and Shockelective neurosurgery treating unspecified brain conditions

Phase 3

Study on the Efficacy and Safety of Gelaspan

CompletedNCT02808325

B. Braun Medical LLCHypovolemia

Start: 2016-06-30End: 2017-06-30Updated: 2017-08-11

Phase 4

Effects of goal-directed fluid management guided by a non-invasive device on the incidence of postoperative complications in neurosurgery: a multicenter, prospective, randomized, controlled study

RecruitingCTIS2024-511153-21-00

Fakultni Nemocnice Brnoelective neurosurgery treating unspecified brain conditions

Start: 2025-11-27Target: 140Updated: 2025-10-14

Unknown Phase

Gelatines in Pediatric PatientS

CompletedNCT02495285

B. Braun Melsungen AGTreatment of Hypovolemia and Shock

Start: 2015-05-31End: 2020-05-31Updated: 2024-12-04

Related Papers

The impact of modified fluid gelatin 4% in a balanced electrolyte solution on plasma osmolality in children—A noninterventional observational study

Pediatric Anesthesia2022-05-192 citations